Preoperative nivolumab to evaluate pathological response in patients with stage I non-small cell lung cancer: a study protocol of phase II trial (POTENTIAL)

INTRODUCTION: Recently, inhibition of programmed cell death 1 or its ligand has shown therapeutic effects on non-small cell lung cancer (NSCLC). However, the effectiveness of preoperative nivolumab monotherapy for stage I NSCLC remains unknown. The present study aimed to investigate the pathological...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMJ Open
Hauptverfasser: Kagimoto, Atsushi, Tsutani, Yasuhiro, Mimae, Takahiro, Miyata, Yoshihiro, Ikeda, Norihiko, Ito, Hiroyuki, Maniwa, Yoshimasa, Suzuki, Kenji, Tsuboi, Masahiro, Yoshimura, Kenichi, Umemoto, Seiji, Okada, Morihito
Format: Artigo
Sprache:Inglês
Veröffentlicht: BMJ Publishing Group 2021
Schlagworte:
Surgery
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7978092/
https://ncbi.nlm.nih.gov/pubmed/33737428
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2020-043234
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge